Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06628661

Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 cm and Microvascular Invasion

Sponsor: Chang Gung Memorial Hospital

View on ClinicalTrials.gov

Summary

The goal of this study is to evaualte the impact of tumor size and microvascular invasion among patients with solitary hepatocellualr carcinoma and post operation. The main questions it aims to answer are: Does the tumor size have more impact on the survival and recurrence than microvascular invasion among solitary operable hepatocellular carcinoma patients? Researchers will retrospectively analyze the prospectively collected clinical database during January 2022 and December 2019 to see whether tumor size more than 6.5 cm or microvascular invasion. The solitary operable hepatocellular carcinoma patients would be classified based on the status of microvascular invasion and tumor size, and the outcome would be evaluated among different sub-populations of the feasible subjects.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

3000

Start Date

2024-09-30

Completion Date

2024-12

Last Updated

2024-11-20

Healthy Volunteers

No

Interventions

PROCEDURE

Surgery for HCC larger than 6.5 cm

Surgery for HCC larger than 6.5 cm without mVI

PROCEDURE

Surgery for HCC larger than 2 cm

Surgery for HCC larger than 2 cm with mVI

Locations (1)

Chang Gung Medical Foundation

Taoyuan District, Taiwan